MAPK pathway-targeted therapies for pediatric low grade gliomas
Pediatric Hematology Oncology Journal · 2023-06 · 8 (2) · 97-101
DOI: 10.1016/j.phoj.2023.04.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Hematology Oncology Journal, 2023-06. Verfasst von Holly B. Lindsay und 2 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The most common pathologic group of childhood brain tumors are low grade gliomas (LGG). LGG comprise a variety of histologies among which pilocytic astrocytoma (WHO grade I) is the most common. Complete resection of LGG portends an excellent prognosis, but this intervention is mainly possible only with hemispheric tumors. For more centrally-located tumors, especially in young children, there is a risk for tumor-related morbidity including visual compromise and endocrinopathies. Given the generally excellent survival outcomes in children with LGG, the goal of interventions is usually to control tumor growth to avoid morbidities. Previously, chemotherapy was the only intervention available for young patients in whom radiation therapy would cause significant neuro-cognitive morbidity. However, with the discovery of the MAPK pathway as the only molecular pathway involved in LGG tumorigenesis, novel classes of drugs known as BRAF and MEK inhibitors have shown great promise and raise the possibility of chronic long-term therapy.
Zitieren
APA
Lindsay, H. B., Mohila, C. A., & Chintagumpala, M. (2023). MAPK pathway-targeted therapies for pediatric low grade gliomas. Pediatric Hematology Oncology Journal, 8(2), 97-101. https://doi.org/10.1016/j.phoj.2023.04.004
Vancouver
Lindsay HB, Mohila CA, Chintagumpala M. MAPK pathway-targeted therapies for pediatric low grade gliomas. Pediatric Hematology Oncology Journal. 2023;8(2):97-101. doi:10.1016/j.phoj.2023.04.004
BibTeX
@article{Lindsay2023,
author = {Lindsay, Holly B. and Mohila, Carrie A. and Chintagumpala, Murali},
title = {MAPK pathway-targeted therapies for pediatric low grade gliomas},
journal = {Pediatric Hematology Oncology Journal},
year = {2023},
volume = {8},
number = {2},
pages = {97--101},
doi = {10.1016/j.phoj.2023.04.004}
}
EUVIMED